logo-loader
viewCytonus Therapeutics

Cytonus Therapeutics to meet with the FDA in 2020 with its immuno-oncology platform technology

Cytonus Therapeutics Inc CEO Dr Remo Moomiaie-Qajar chatted with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. Based in Columbus, Ohio, the cell-based platform technology company is focused on immuno-oncology and gene therapies for cancer and rare diseases.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Helix Technologies following up strong 2019 with success in 2020

Helix Technologies (OTCQB: HLIX) President of Data Services Garvis Toler joined Steve Darling from Proactive Vancouver to discuss the company releasing their 2019 financial numbers which were very strong and also what milestones they hit to close the year.  Toler also told Proactive...

2 days, 13 hours ago

2 min read